Amgen IncNASDAQ:AMGN
- LAST PRICE332.0600
- TODAY'S CHANGE (%)1.9100 (0.5785%)
- Bid / Lots331.8100/ 4
- Ask / Lots332.0600/ 1
- Open / Previous Close330.4600 / 330.1500
- Day Range
- 52 Week Range
- Volume335,382
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | AMGN |
|---|---|---|
| 09:32 ET | 24739 | 329.11 |
| 09:34 ET | 5499 | 328.43 |
| 09:36 ET | 1552 | 329.165 |
| 09:38 ET | 3109 | 330.1799 |
| 09:39 ET | 1200 | 330.15 |
| 09:41 ET | 900 | 329.23 |
| 09:43 ET | 2700 | 329.3 |
| 09:45 ET | 2299 | 329.97 |
| 09:48 ET | 2829 | 330.848 |
| 09:50 ET | 2700 | 330.9 |
| 09:52 ET | 8599 | 331.775 |
| 09:54 ET | 6687 | 332.1 |
| 09:56 ET | 378 | 332.81 |
| 09:57 ET | 7127 | 333.22 |
| 09:59 ET | 5372 | 334.05 |
| 10:01 ET | 5031 | 334.74 |
| 10:03 ET | 4941 | 335.1 |
| 10:06 ET | 2750 | 335.56 |
| 10:08 ET | 2637 | 335.105 |
| 10:10 ET | 6410 | 334.955 |
| 10:12 ET | 10423 | 334.15 |
| 10:14 ET | 4175 | 334.61 |
| 10:15 ET | 1666 | 334.4315 |
| 10:17 ET | 2430 | 334.5 |
| 10:19 ET | 7252 | 334.23 |
| 10:21 ET | 7015 | 334.435 |
| 10:24 ET | 4565 | 334.195 |
| 10:26 ET | 1930 | 333.9335 |
| 10:28 ET | 7336 | 334.28 |
| 10:30 ET | 9117 | 334.14 |
| 10:32 ET | 1650 | 333.655 |
| 10:33 ET | 2111 | 334.15 |
| 10:35 ET | 900 | 334.3087 |
| 10:37 ET | 628 | 334.75 |
| 10:39 ET | 1549 | 334.54 |
| 10:42 ET | 3752 | 334.34 |
| 10:44 ET | 740 | 334.3 |
| 10:46 ET | 1218 | 334.075 |
| 10:48 ET | 2170 | 333.64 |
| 10:50 ET | 5900 | 333.025 |
| 10:51 ET | 3967 | 333.21 |
| 10:53 ET | 2886 | 332.995 |
| 10:55 ET | 1250 | 332.42 |
| 10:57 ET | 1966 | 332.425 |
| 11:00 ET | 2253 | 332.32 |
| 11:02 ET | 3301 | 331.66 |
| 11:04 ET | 2862 | 331.775 |
| 11:06 ET | 2906 | 331.68 |
| 11:08 ET | 1755 | 332.02 |
| 11:09 ET | 300 | 332.06 |
Jul 12, 2024
DJ Amgen on Track for Record High Close -- Data Talk, from 11:07AM ET on Friday Jul 12, 2024 by Dow Jones
11:07AM ET on Friday Jul 12, 2024 by Dow Jones
Jul 11, 2024
DJ Amgen Is Maintained at Equal-Weight by Morgan Stanley, from 1:17PM ET on Thursday Jul 11, 2024 by Dow Jones
1:17PM ET on Thursday Jul 11, 2024 by Dow JonesDJ Amgen on Track for Record High Close -- Data Talk, from 12:00PM ET on Thursday Jul 11, 2024 by Dow Jones
12:00PM ET on Thursday Jul 11, 2024 by Dow Jones
Jun 27, 2024
DJ Amgen Is Maintained at Buy by Argus Research, from 1:57PM ET on Thursday Jun 27, 2024 by Dow Jones
1:57PM ET on Thursday Jun 27, 2024 by Dow Jones
Jun 25, 2024
DJ Amgen on Track for Record High Close -- Data Talk, from 10:20AM ET on Tuesday Jun 25, 2024 by Dow Jones
10:20AM ET on Tuesday Jun 25, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Amgen Inc | 177.1B | 47.4x | -0.22% |
Gilead Sciences Inc | 88.2B | 199.9x | +1.53% |
AstraZeneca PLC | 243.8B | 38.6x | +17.52% |
Novartis AG | 242.8B | 25.0x | -5.59% |
Haleon PLC | 39.5B | 28.9x | --- |
Pfizer Inc | 164.9B | -482.1x | -7.10% |
Company Information
Amgen Inc. is a biotechnology company. The Company discovers, develops, manufactures and delivers various human therapeutics. It focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and improve people's lives. It operates in human therapeutics segment. The Company’s marketed products portfolio includes Aranesp, ENBREL, Prolia (denosumab), Neulasta (pegfilgrastim), Otezla, XGEVA, Aranesp (darbepoetin alfa), KYPROLIS, Repatha (evolocumab), Nplate (romiplostim), Vectibix (panitumumab), MVASI (bevacizumab-awwb), Parsabiv (etelcalcetide), EPOGEN (epoetin alfa), KANJINTI (trastuzumab-anns), BLINCYTO (blinatumomab), Aimovig (erenumab-aooe), EVENITY (romosozumab-aqqg), AMGEVITATM (adalimumab), Sensipar/Mimpara (cinacalcet), NEUPOGEN (filgrastim), IMLYGIC (talimogene laherparepvec), Corlanor (ivabradine), KYPROLIS (carfilzomib), Maridebart cafraglutide, (infliximab-axxq), Evenity, LumaKras, Nplate and XGeva, others.
Contact Information
- Headquarters
- One Amgen Center DriveTHOUSAND OAKS, CA, United States 91320
- Phone
- 805-447-1000
- Fax
- 805-447-1010
Executives
- Chairman of the Board, President, Chief Executive Officer
- Robert Bradway
- Chief Financial Officer, Executive Vice President
- Peter Griffith
- Executive Vice President, Chief Technology Officer
- David Reese
- Executive Vice President, Research and Development, and Chief Scientific Officer
- James Bradner
- Executive Vice President, General Counsel, Secretary
- Jonathan Graham
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $177.1B |
|---|---|
Revenue (TTM) | $29.5B |
Shares Outstanding | 536.4M |
Dividend Yield | 2.71% |
Annual Dividend Rate | 9.0000 USD |
Ex-Dividend Date | 05-16-24 |
Pay Date | 06-07-24 |
Beta | 0.58 |
EPS | $7.00 |
Book Value | $11.64 |
P/E Ratio | 47.4x |
Price/Sales (TTM) | 6.0 |
Price/Cash Flow (TTM) | 21.3x |
Operating Margin | 24.42% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
